We are live on ! Find out more
TLSA icon

Tiziana Life Sciences
TLSA

25 hedge funds and large institutions have $4.15M invested in Tiziana Life Sciences in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 3

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

4% more funds holding

Funds holding: 24 → 25 (+1)

4% more capital invested

Capital invested by funds: $3.97M → $4.15M (+$177K)

0% less ownership

Funds ownership: 5.21% → 5.21% (-0%)

Holders
25
Holders Change
+1
Holders Change %
+4.17%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
10
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
+$34.6K
2
Morgan Stanley
Morgan Stanley
New York
+$23.4K
3
Citigroup
Citigroup
New York
+$19.4K
4
UBS Group
UBS Group
Switzerland
+$12.3K
5
Jane Street
Jane Street
New York
+$7.63K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$78.6K
2
Citadel Advisors
Citadel Advisors
Florida
-$37K
3
CS
Credit Suisse
Switzerland
-$1.88K
4
HighTower Advisors
HighTower Advisors
Illinois
-$1.43K
Name Holding Trade Value Shares
Change 		Change in
Stake
HighTower Advisors
1
HighTower Advisors
Illinois
$3.22M -$1.43K -1,900 -0%
HSBC Holdings
2
HSBC Holdings
United Kingdom
$234K – – –
State Street
3
State Street
Massachusetts
$170K -$78.6K -104,442 -32%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$151K +$4.82K +6,399 +3%
Morgan Stanley
5
Morgan Stanley
New York
$142K +$23.4K +31,083 +21%
AFP
6
Ausdal Financial Partners
Iowa
$44K – – –
CF
7
Cantor Fitzgerald
New York
$36K +$34.6K +45,991 New
Citigroup
8
Citigroup
New York
$22K +$19.4K +25,738 +836%
Bank of America
9
Bank of America
North Carolina
$20K +$90 +119 +0.4%
WAM
10
Warberg Asset Management
Illinois
$17K – – –
ZF
11
Zhang Financial
Michigan
$16K +$1.13K +1,500 +8%
UBS Group
12
UBS Group
Switzerland
$16K +$12.3K +16,313 +300%
Barclays
13
Barclays
United Kingdom
$14K – – –
VF
14
Virtu Financial
New York
$12K +$2.25K +2,981 +24%
TRCT
15
Tower Research Capital (TRC)
New York
$12K +$7.09K +9,410 +158%
Jane Street
16
Jane Street
New York
$8K +$7.63K +10,139 New
IA
17
IFP Advisors
Florida
$3K +$902 +1,198 +240%
CS
18
Credit Suisse
Switzerland
$2K -$1.88K -2,500 -46%
Group One Trading
19
Group One Trading
Illinois
$2K – – –
Osaic Holdings
20
Osaic Holdings
Arizona
$2K +$2.31K +3,072 +61,440%
BlackRock
21
BlackRock
New York
$1K – – –
Northwestern Mutual Wealth Management
22
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
Citadel Advisors
23
Citadel Advisors
Florida
– -$37K -49,535 Closed

TLSA Hedge Fund Activity: Q3 2022 in Review

25 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q3 2022, worth a combined $4.15M — up 4.5% from $3.97M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new TLSA positions and 1 closed out — a net gain of 1 holder — while 10 added to existing stakes and 3 trimmed.

The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $34.6K. The largest seller was State Street, cutting an estimated $78.6K.

  • 25 institutional investors held Tiziana Life Sciences (TLSA) as of Q3 2022, up from 24 in Q2 2022.
  • Funds reported $4.15M of Tiziana Life Sciences stock for Q3 2022, up 4.5% quarter-over-quarter.
  • 2 funds opened new Tiziana Life Sciences positions in Q3 2022 and 1 closed out, a net change of +1 holder.
  • The largest Tiziana Life Sciences buyer in Q3 2022 was Cantor Fitzgerald, an estimated $34.6K added.
  • The largest Tiziana Life Sciences seller in Q3 2022 was State Street, an estimated $78.6K sold.

Based on aggregated 13F filings for Q3 2022.